Adan Z. Becerra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Adan Z. Becerra has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
Dana M. Hayden
Department of Surgery, Rush University Medical Center, Chicago, IL https://twitter.com/dmhayden21
5 shared publications- Christopher Thomas Aquina
Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, United States
4 shared publications Miles W. Grunvald
Department of Surgery, Rush University Medical Center, Chicago, USA
4 shared publicationsAnuradha R. Bhama
Department of Surgery, Rush University Medical Center, Chicago, Illinois
3 shared publicationsCristina M. O’donoghue
Rush Univ, Med Ctr, Dept Surg, Chicago, IL 60612 USA
3 shared publicationsMarek A. Hansdorfer
Division of Plastic and Reconstructive Surgery, Rush University Medical Center, Chicago, Ill
3 shared publications
Latest Publications
- Open Access
- 1 February 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 11 (2) , e4839
Safety and Efficacy of Extended Postdischarge Venous Thromboembolism Prophylaxis in Microsurgical Breast Reconstruction
Background: Discharging patients on extended postoperative venous thromboembolism (VTE) prophylaxis is trending in microsurgical breast reconstruction (MBR). This study investigated contemporary bleeding and thromboembolic complications after MBR and reported postdischarge enoxaparin outcomes. Methods: The PearlDiver database was queried for MBR patients who did not receive postdischarge VTE prophylaxis (cohort 1) and MBR patients discharged with enoxaparin for at least 14 days (cohort 2), then queried for hematoma, deep venous thrombosis (DVT), and/or pulmonary embolism. Concurrently, a systematic review was undertaken to identify studies investigating VTE with postoperative chemoprophylaxis. Results: In total, 13,541 patients in cohort 1 and 786 patients in cohort 2 were identified. The incidence of hematoma, DVT, and pulmonary embolism were 3.51%, 1.01%, 0.55% in cohort 1, and 3.31%, 2.93%, and 1.78% in cohort 2, respectively. There was no significant difference in hematoma between these two cohorts (P = 0.767); however, a significantly lower rate of DVT (P < 0.001) and pulmonary embolism (P < 0.001) occurred in cohort 1. Ten studies met systematic review inclusion. Only three studies reported significantly lower VTE rates with postoperative chemoprophylaxis. Seven studies found no difference in bleeding risk. Conclusions: This is the first study utilizing a national database and a systematic review to investigate extended postoperative enoxaparin in MBR. Overall, rates of DVT/PE seem to be declining compared with previous literature. The results of this study suggest that there remains a lack of evidence supporting extended postoperative chemoprophylaxis, although the therapy appears safe in that it does not increase bleeding risk.
- 1 February 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 11 (2) , e4839
Open AccessSafety and Efficacy of Extended Postdischarge Venous Thromboembolism Prophylaxis in Microsurgical Breast Reconstruction
Background: Discharging patients on extended postoperative venous thromboembolism (VTE) prophylaxis is trending in microsurgical breast reconstruction (MBR). This study investigated contemporary bleeding and thromboembolic complications after MBR and reported postdischarge enoxaparin outcomes. Methods: The PearlDiver database was queried for MBR patients who did not receive postdischarge VTE prophylaxis (cohort 1) and MBR patients discharged with enoxaparin for at least 14 days (cohort 2), then queried for hematoma, deep venous thrombosis (DVT), and/or pulmonary embolism. Concurrently, a systematic review was undertaken to identify studies investigating VTE with postoperative chemoprophylaxis. Results: In total, 13,541 patients in cohort 1 and 786 patients in cohort 2 were identified. The incidence of hematoma, DVT, and pulmonary embolism were 3.51%, 1.01%, 0.55% in cohort 1, and 3.31%, 2.93%, and 1.78% in cohort 2, respectively. There was no significant difference in hematoma between these two cohorts (P = 0.767); however, a significantly lower rate of DVT (P < 0.001) and pulmonary embolism (P < 0.001) occurred in cohort 1. Ten studies met systematic review inclusion. Only three studies reported significantly lower VTE rates with postoperative chemoprophylaxis. Seven studies found no difference in bleeding risk. Conclusions: This is the first study utilizing a national database and a systematic review to investigate extended postoperative enoxaparin in MBR. Overall, rates of DVT/PE seem to be declining compared with previous literature. The results of this study suggest that there remains a lack of evidence supporting extended postoperative chemoprophylaxis, although the therapy appears safe in that it does not increase bleeding risk.
- Open Access
- 1 December 2022
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 157 (12) , 1159-1162
Association Between Mental Health Conditions and Postoperative Complications After Gender-Affirming Surgery
Approximately 0.6% of the US population identifies as transgender, and the number of individuals seeking gender-affirming surgery (GAS) is rapidly increasing.1 Almazan and Keuroghlian2 recently identified the mental health benefits associated with GAS. Using the 2015 US Transgender Survey, they found that individuals who underwent GAS had lower odds of psychological distress, tobacco smoking, and suicidal ideation compared with those who did not undergo GAS.2 However, established mental health condition diagnoses may be risk factors for postoperative complications.
- 1 December 2022
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 157 (12) , 1159-1162
Open AccessAssociation Between Mental Health Conditions and Postoperative Complications After Gender-Affirming Surgery
Approximately 0.6% of the US population identifies as transgender, and the number of individuals seeking gender-affirming surgery (GAS) is rapidly increasing.1 Almazan and Keuroghlian2 recently identified the mental health benefits associated with GAS. Using the 2015 US Transgender Survey, they found that individuals who underwent GAS had lower odds of psychological distress, tobacco smoking, and suicidal ideation compared with those who did not undergo GAS.2 However, established mental health condition diagnoses may be risk factors for postoperative complications.
- 13 November 2022
- Published by Wiley in Colorectal Disease
- Vol. 25 (3) , 404-412
Major renal morbidity following elective rectal cancer resection by the type of diverting ostomy
Aim: Patients with rectal cancer often undergo faecal diversion, yet the existing literature cursorily reports renal sequelae by the type of ostomy. We aimed to determine whether the presence of an ileostomy or colostomy was associated with postoperative renal morbidity.Methods: We identified patients with rectal cancer undergoing elective resection with primary anastomosis without diversion, with an ileostomy and with a colostomy by 21 possible procedures in the colectomy‐ and proctectomy‐specific National Surgical Quality Improvement Program files. The odds of major renal events (renal failure [dialysis initiated] or progressive renal insufficiency [>2 mg/dl increase in creatinine without dialysis]), progressive renal insufficiency alone and readmissions were assessed using propensity score weighting and logistic regression.Results: Of 15 075 patients (63.7% Stage II–III, 85.7% creatinine values obtained ≤30 days preoperatively), 37.7% were not diverted, 39.5% had an ileostomy and 22.9% a colostomy. Compared to non‐diverted patients, diversion was associated with major renal events (ileostomy, odds ratio [OR] 2.1, 95% confidence interval [CI] 1.6–2.9; colostomy, OR 1.8, 95% CI 1.3–2.5), progressive renal insufficiency (ileostomy, OR 2.5, 95% CI 1.7–3.5; colostomy, OR 2.0, 95% CI 1.4–2.9), readmissions for renal failure (ileostomy, OR 3.2, 95% CI 2.1–5.0; colostomy, OR 2.5, 95% CI 1.6–4.1) and readmissions for fluid/electrolyte abnormalities (ileostomy, OR 2.3, 95% CI 1.6–3.3; colostomy, OR 1.8, 95% CI 1.2–2.6).Conclusion: Diverting ostomies after elective rectal cancer resection are strongly associated with renal morbidity. The decision to divert is complex, and it is unclear whether select patients may benefit from a colostomy from a renal perspective.
- 13 November 2022
- Published by Wiley in Colorectal Disease
- Vol. 25 (3) , 404-412
Major renal morbidity following elective rectal cancer resection by the type of diverting ostomy
Aim: Patients with rectal cancer often undergo faecal diversion, yet the existing literature cursorily reports renal sequelae by the type of ostomy. We aimed to determine whether the presence of an ileostomy or colostomy was associated with postoperative renal morbidity.Methods: We identified patients with rectal cancer undergoing elective resection with primary anastomosis without diversion, with an ileostomy and with a colostomy by 21 possible procedures in the colectomy‐ and proctectomy‐specific National Surgical Quality Improvement Program files. The odds of major renal events (renal failure [dialysis initiated] or progressive renal insufficiency [>2 mg/dl increase in creatinine without dialysis]), progressive renal insufficiency alone and readmissions were assessed using propensity score weighting and logistic regression.Results: Of 15 075 patients (63.7% Stage II–III, 85.7% creatinine values obtained ≤30 days preoperatively), 37.7% were not diverted, 39.5% had an ileostomy and 22.9% a colostomy. Compared to non‐diverted patients, diversion was associated with major renal events (ileostomy, odds ratio [OR] 2.1, 95% confidence interval [CI] 1.6–2.9; colostomy, OR 1.8, 95% CI 1.3–2.5), progressive renal insufficiency (ileostomy, OR 2.5, 95% CI 1.7–3.5; colostomy, OR 2.0, 95% CI 1.4–2.9), readmissions for renal failure (ileostomy, OR 3.2, 95% CI 2.1–5.0; colostomy, OR 2.5, 95% CI 1.6–4.1) and readmissions for fluid/electrolyte abnormalities (ileostomy, OR 2.3, 95% CI 1.6–3.3; colostomy, OR 1.8, 95% CI 1.2–2.6).Conclusion: Diverting ostomies after elective rectal cancer resection are strongly associated with renal morbidity. The decision to divert is complex, and it is unclear whether select patients may benefit from a colostomy from a renal perspective.
- 29 August 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (12) , 1
ASO Visual Abstract: Mediating Factors of Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer
- 29 August 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (12) , 1
ASO Visual Abstract: Mediating Factors of Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer
- 5 July 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 224 (5) , 1301-1307
Social determinants of health Z-codes and postoperative outcomes after colorectal surgery: A national population-based study
- 5 July 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 224 (5) , 1301-1307
Social determinants of health Z-codes and postoperative outcomes after colorectal surgery: A national population-based study
- 4 July 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (12) , 1-2
ASO Author Reflections: Applying the Counterfactual Approach to Disparities in Breast Cancer Treatment Delays
- 4 July 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (12) , 1-2
ASO Author Reflections: Applying the Counterfactual Approach to Disparities in Breast Cancer Treatment Delays
- 24 June 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (12) , 7652-7658
Factors Mediating Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer
Despite improvements, disparities in breast cancer care have led to an inequitable distribution of treatment delays and worse outcomes among patients with
- 24 June 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (12) , 7652-7658
Factors Mediating Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer
Despite improvements, disparities in breast cancer care have led to an inequitable distribution of treatment delays and worse outcomes among patients with
- 23 March 2022
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 40 (7) , 343.e15-343.e20
Disparities in patient and system factors explain racial/ethnic disparities in delayed time to treatment in muscle invasive bladder cancer
- 23 March 2022
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 40 (7) , 343.e15-343.e20
Disparities in patient and system factors explain racial/ethnic disparities in delayed time to treatment in muscle invasive bladder cancer